Success Metrics

Clinical Success Rate
87.5%

Based on 7 completed trials

Completion Rate
88%(7/8)
Active Trials
0(0%)
Results Posted
71%(5 trials)
Terminated
1(13%)

Phase Distribution

Ph phase_4
1
13%
Ph phase_1
1
13%
Ph phase_2
3
38%
Ph not_applicable
3
38%

Phase Distribution

1

Early Stage

3

Mid Stage

1

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
1(12.5%)
Phase 2Efficacy & side effects
3(37.5%)
Phase 4Post-market surveillance
1(12.5%)
N/ANon-phased studies
3(37.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

87.5%

7 of 8 finished

Non-Completion Rate

12.5%

1 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Completed(7)
Terminated(1)

Detailed Status

Completed7
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
87.5%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (12.5%)
Phase 23 (37.5%)
Phase 41 (12.5%)
N/A3 (37.5%)

Trials by Status

completed788%
terminated113%

Recent Activity

0 active trials
Showing 5 of 8
completednot_applicable

Information Systems Connectivity to Improve Medication Process

NCT06728254
completedphase_4

Personalized Treatments for Depressive Symptoms in Patients With Advanced Heart Failure

NCT03688100
completedphase_2

Veterans' Pain Care Organizational Improvement Comparative Effectiveness Study

NCT03026790
completedphase_2

Comparing Smoking Treatment Programs for Lighter Smokers - 1

NCT00086411
completedphase_1

Open-Label Pilot Study of Lisdexamfetamine for Cocaine Dependence

NCT01486810
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT06728254Not Applicable

Information Systems Connectivity to Improve Medication Process

Completed
NCT03688100Phase 4

Personalized Treatments for Depressive Symptoms in Patients With Advanced Heart Failure

Completed
NCT03026790Phase 2

Veterans' Pain Care Organizational Improvement Comparative Effectiveness Study

Completed
NCT00086411Phase 2

Comparing Smoking Treatment Programs for Lighter Smokers - 1

Completed
NCT01486810Phase 1

Open-Label Pilot Study of Lisdexamfetamine for Cocaine Dependence

Completed
NCT02882048Not Applicable

Auricular Acupuncture to Facilitate Outpatient Opioid Weaning

Terminated
NCT01032135Phase 2

Adaptive Treatment for Alcohol and Cocaine Dependence

Completed
NCT00570427Not Applicable

Improving Depression Treatment for Older Minority Adults

Completed

All 8 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
8